vividlook icad

At this year’s RSNA, computer-aided detection (CAD) solutions target MRI. These new CAD systems include:

• VividLook MRI prostate analysis solution, provides more diagnostic information by utilizing all available time points (ATP), creating colorized images based on signal changes defined by tumor physiology. This post processing software package is designed to provide a reliable means of visualizing the presence and pattern of contrast induced enhancement of MRI images in the prostate, helping radiologists distinguish benign from malignant lesions.

• SpectraLook CAD technology is designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of the MRI procedure results. It provides radiologists with more diagnostic information by creating colorized images based on direct signal changes due to contrast agent influx and efflux rates using key physiological measures that relate to tumor physiology. These physiological markers can aid in the analysis of large MR data sets.

• PrecisionPoint, iCAD’s interventional planning solution for breast MRI, provides radiologists with an automatic calculation of the location and depth of a targeted region of interest making biopsies easier, faster, and more reliable for both grid and post and pillar methods. PrecisionPoint is an integrated module within CADvue, iCAD’s MRI review software solution. Using CADvue and PrecisionPoint, radiologists have a quick, easy way to secure all the necessary data for an interventional procedure, streamlining their planning and performance of MRI-guided percutaneous breast biopsies.

• CADvue is iCAD’s MRI review software and analysis solution that facilitates the analysis of ATP colorized images and quantitative data. CADvue allows the user to create standard and customized reports that enable the radiologist to communicate time-sensitive breast and prostate MR study results to referring physicians. CADvue software also provides an efficient method for clinicians to compare studies of the same patient performed over time to assess the morphology and kinetic changes. CADvue compares several parameters including EVF, PERM, and volume of selected regions of interest enabling improved quantitative analysis.

 


Related Content

News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now